Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroinflammation After Myocardial Infarction - Imaging Substudy
NCT03968445Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2019
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of DPA-714 in myocardial infarction (MI) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: TPSO-PET measurement of neuroinflammation at 2 years. Started Oct 2019; status: completed.
02
Drugs
DPA-714
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03968445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03968445.